Cargando…
The addition of anlotinib reduces the incidence of radiation and immunotherapy-induced pneumonia
Autores principales: | Yang, Linlin, Zhao, Qian, Yu, Jinming, Wang, Linlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544367/ https://www.ncbi.nlm.nih.gov/pubmed/37779202 http://dx.doi.org/10.1186/s12967-023-04500-0 |
Ejemplares similares
-
XPO1-mutant NSCLC without STK11/KEAP1 mutations may predict better survival to immunotherapy
por: Li, Xuanzong, et al.
Publicado: (2021) -
Precise Therapeutic Benefits and Underlying Mechanisms of Anlotinib Combined With Checkpoint Immunotherapy in Advanced Non-Small-Cell Lung Cancer
por: Xiang, Yi, et al.
Publicado: (2022) -
Berberine reduces neuroglia activation and inflammation in streptozotocin-induced diabetic mice
por: Liu, Mei, et al.
Publicado: (2019) -
Severe Pulmonary Toxicity With Concurrent Anlotinib and Chemoradiotherapy in Stage III NSCLC: The ALTER-L042 Phase 1 Clinical Trial
por: Zhu, Hui, et al.
Publicado: (2022) -
Surgical resection following therapy with anlotinib in locally advanced papillary thyroid carcinoma: a case description
por: Zhang, Jing, et al.
Publicado: (2023)